Table 1 Descriptive data
Intervention group (n = 57) | Historical group (n = 73) | |
|---|---|---|
Birth weight, g | 852 ± 253 | 854 ± 240 |
Gestational age, weeks | 26 ± 2.2 | 26 ± 2.2 |
Males, n (%) | 30 (52.6) | 40 (54.8) |
SGA, n (%) | 15 (26.3) | 19 (26.0) |
Twins, n (%) | 19 (33.3) | 30 (41.1) |
Apgar 1′ | 5.1 (1.8) | 5.0 (1.9) |
Apgar 5′ | 7.8 (0.9) | 7.8 (1.05) |
Infants receiving artificial surfactant, n (%) | 50 (87.7) | 63 (86.3) |
Infants treated with prenatal steroids, n (%) | 45 (78.9) | 52 (71.2) |
Infants treated with postnatal steroids, n (%) | 19 (33) | 14 (19.2) |
Infants receiving diuretic therapy, n (%) | 47 (82.5)* | 33 (45.2) |
Days of assisted ventilation | 41.26 (51.13) | 36.5(37.4) |
Days of supplemental oxygen therapy | 25.8 (26.1) | 29.1 (30.7) |
Mild and moderate BPD, n (%) | 36 (63.2) | 48 (65.7) |
Severe BPD, n (%) | 21 (36.8) | 25 (34.2) |
Patent ductus arteriosus, n (%) | 36 (63.2) | 43 (58.9) |
Necrotizing enterocolitis, n (%) | 2 (3.5) | 3 (4.1) |
Intraventricular hemorrhage, n (%) | 10 (17.5) | 19 (26.0) |
Retinopathy of prematurity, n (%) | 21 (36.8) | 21 (28.8) |
Sepsis, n (%) | 7 (12.3) | 15 (20.5) |
Infants with tube feeding at discharge, n (%) | 7 (9.6) | 3 (5.3) |